Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SalusXLJU:SALR -1.47%75 Days Payable is 65.49 as of Mar. 2026, which is 3% above its 10-year median of 63.30. GuruFocus rates XLJU:SALR with a GF Score™ of 75/100 and a GF Value™ of €32.73 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 117 Medical Distribution companies, Salus ranks worse than 56.41% on this metric.
Salus's average Accounts Payable for the
three
months ended in Mar. 2026 was €124.3 Mil. Salus's Cost of Goods Sold for the
three
months ended in Mar. 2026 was €173.3 Mil.
Hence, Salus's Days Payable for the
three
months ended in Mar. 2026 was 65.49.
The historical rank and industry rank for Salus's Days Payable or its related term are showing as below:
XLJU:SALR'
s Days Payable Range Over the Past 10 Years
Min: 59.35 Med: 63.3 Max: 73.72
Current: 65.33
During the past 13 years, Salus's highest Days Payable was 73.72. The lowest was 59.35. And the median was 63.30.
XLJU:SALR's Days Payable is ranked worse than 56.41% of 117
companies
in the Medical Distribution industry
Industry Median: 76.68
vs XLJU:SALR: 65.33
Salus's Days Payable
increased
from Mar. 2025 (64.99) to Mar. 2026 (65.49).
It may suggest that Salusdelayed paying its suppliers.
The historical data trend for Salus's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XLJU:SALR vs MCK, COR, CAH: Days Payable Comparison
For the Medical Distribution subindustry, Salus's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Salus Days Payable vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Salus's Days Payable distribution charts can be found below:
* The bar in red indicates where Salus's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Salus's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Salus (XLJU:SALR) has a Days Payable of 65.49 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Salus and its competitors. This is near median its historical median of 63.30. Over the past decade, Salus' Days Payable has ranged from 59.35 to 73.72. According to the industry distribution chart, Salus ranks #66 out of 117 companies in the Medical Distribution industry, placing it in the top 56.4%.
Is Salus' Days Payable too high?
Salus' current Days Payable of 65.49 is near median its 10-year median of 63.30. Over the past 10 years, this metric has ranged from a low of 59.35 to a high of 73.72. The Medical Distribution industry median Days Payable is 76.68. Salus' value of 65.49 is 14.6% below this industry median. Based on the distribution chart, Salus ranks #66 out of 117 companies in the Medical Distribution industry, which is below the industry midpoint. Overall, Salus has a GF Score™ of 75/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Salus' Days Payable compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Salus ranks #66 out of 117 companies for Days Payable. This places Salus in the lower half of its industry. The industry median Days Payable is 76.68. Salus' value of 65.49 is 14.6% below this benchmark. Historically, Salus' own Days Payable has ranged from 59.35 to 73.72 over the past decade. While the company's 10-year median is 63.30 vs. the industry median of 76.68, Salus has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Distribution company?
The median Days Payable among Medical Distribution companies is 76.68, based on 117 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Salus's current Days Payable of 65.49 is 14.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Salus and its competitors. For the Medical Distribution industry, the median Days Payable is 76.68 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Salus's current Days Payable is 65.49, which is near median its own 10-year median of 63.30. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Salus stock overvalued right now?
Based on GuruFocus' analysis, Salus (XLJU:SALR) is currently considered Significantly Overvalued. The stock's GF Value™ is €32.73, compared to a current price of €67.00 — trading 104.7% above its estimated fair value. The current Days Payable is 65.49, which is near median its 10-year median of 63.30 and 14.6% below the Medical Distribution industry median of 76.68. Salus' overall GF Score™ is 75/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Salus (XLJU:SALR), the current Days Payable is 65.49 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Salus (XLJU:SALR) Overvalued in 2026?
Based on GuruFocus' analysis, Salus stock appears to be overvalued.
The current stock price of €67.00 is trading 104.7% above its estimated GF Value™ of €32.73.
GuruFocus considers Salus to be Significantly Overvalued.
Key valuation signals for XLJU:SALR:
Days Payable: 65.49 (near median its 10-year median of 63.30)
GF Value™: €32.73 vs. price of €67.00 (104.7% above fair value)
Industry Position: 14.6% below the Medical Distribution median (#66 of 117)
No single metric tells the full story. See the XLJU:SALR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Salus is a Slovenia-based company engaged in the wholesale and distribution of medical products. It offers medicines, medical devices, medical supplies, dietary supplements, cosmetics to hospitals, pharmacies, and other customers.
75GF Score
Get the complete analysis for XLJU:SALR
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XLJU:SALR has been successfully added to your 
